<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02850497</url>
  </required_header>
  <id_info>
    <org_study_id>875/13</org_study_id>
    <nct_id>NCT02850497</nct_id>
  </id_info>
  <brief_title>6-month Intracoronary Optical Coherence Tomography (OCT) Evaluation of Three New Generation Drug Eluting Stent</brief_title>
  <acronym>CREBX-OCT</acronym>
  <official_title>6-month Intracoronary Optical Coherence Tomography (OCT) Evaluation of Endothelization and Malapposition of Three New Generation Drug Eluting Stent: CRE8, Biomatrix and Xience</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Azienda Ospedaliero-Universitaria Careggi</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Azienda Ospedaliero-Universitaria Careggi</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aim of this study is to compare at 6 months follow-up, endothelization and malapposition,
      evaluated by means of optical coherence tomography, in terms of number of struts not
      endothelized or malapposed, after the implantation of three new generation stent: Cre8,
      Biomatrix and Xience.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a randomized study aimed at evaluating in 60 patients with either acute coronary
      syndromes or stable coronary artery disease submitted with PCI and stenting, endothelization
      and malapposition at 6 months follow-up (primary endpoint), evaluated by means of optical
      coherence tomography in terms of number of struts not re-endothelized or malapposed, after
      the implantation of three new generation stent: Cre8, Biomatrix and Xience. Further clinical
      follow-up will be performed to evaluate MACE at 12 months follow-up.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2013</start_date>
  <completion_date type="Actual">April 2016</completion_date>
  <primary_completion_date type="Actual">April 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>stent struts coverage assessed by means of intracoronary optical coherence tomography</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>MACE (cardiovascular death, myocardial infarction, stroke and target vessel revascularization)</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>inducible ischemia at myocardial scintigraphy</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Recurrent Angina After Coronary Stent Placement</condition>
  <arm_group>
    <arm_group_label>CRE8 stent</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Treatment with CRE8 stent implantation and evaluated with optical coherence tomography at 6 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Biomatrix stent</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Treatment with Biomatrix stent implantation and evaluated with optical coherence tomography at 6 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>patients treated with Xience stent</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Treatment with Xience stent implantation and evaluated with optical coherence tomography at 6 months</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>optical coherence tomography at 6 months</intervention_name>
    <description>6-month evaluation of malapposition and endothelization with the use of intracoronary optical coherence tomography</description>
    <arm_group_label>CRE8 stent</arm_group_label>
    <arm_group_label>Biomatrix stent</arm_group_label>
    <arm_group_label>patients treated with Xience stent</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with stable angina or acute coronary syndromes submitted to coronary
             angioplasty on a coronary with a vessel diameter &gt; 2,5 mm

        Exclusion Criteria:

          -  Known allergy to antithrombotic drugs or to other components of the stent studied
             Planned surgery 6 months within angioplasty
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Cristina Giglioli, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Azienda Ospedaliero-Universitaria Careggi, Florence, Italy</affiliation>
  </overall_official>
  <removed_countries>
    <country>Italy</country>
  </removed_countries>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 30, 2015</study_first_submitted>
  <study_first_submitted_qc>July 29, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 1, 2016</study_first_posted>
  <last_update_submitted>August 16, 2016</last_update_submitted>
  <last_update_submitted_qc>August 16, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 17, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Azienda Ospedaliero-Universitaria Careggi</investigator_affiliation>
    <investigator_full_name>Cristina Giglioli, MD</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>optical coherence tomography</keyword>
  <keyword>malapposition</keyword>
  <keyword>endothelization</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>To date a decision has not been taken with regard to a possible plan to share data</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

